StemCyte Taiwan Co., Ltd.
A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy
Cerebral Palsy
hUCB
Phase 1
This is a phase I study to evaluate the safety and efficacy in hUCB treatment on the patients with cerebral palsy (CP).
| Study Type : | Interventional |
| Estimated Enrollment : | 12 participants |
| Masking : | Double |
| Primary Purpose : | Treatment |
| Official Title : | A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children With Cerebral Palsy |
| Actual Study Start Date : | September 2024 |
| Estimated Primary Completion Date : | September 2026 |
| Estimated Study Completion Date : | December 2026 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: hUCB treatment Human cord blood infusion |
|
|
No Intervention: Placebo treatment Placebo infusion |
| Ages Eligible for Study: | 1 Year to 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.